SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 -- Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased ]

By | 2016-10-21T14:18:38+00:00 October 21st, 2016|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ:

[Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 -- Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased ]

By | 2016-10-21T14:19:40+00:00 October 21st, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] SC 13G: SCHEDULE 13G CUSIP No. 090678301 Page 2 of

[SCHEDULE 13G CUSIP No. 090678301 Page 2 of 9 Pages (1) Names of Reporting Persons. Mitchell P. Kopin (2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐ (3) SEC Use Only (4) Citizenship or Place of Organization Number of Shares Beneficially Owned by Each Reporting Per]

By | 2016-10-20T03:02:51+00:00 October 19th, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. Issuance Date Date of Issuance: October [•], 2016 (“ Company Holder 1 16 Securities Purchase Agreement Biostar Pharmaceuticals, Inc., a Maryland corporation (the “ 1. Mechanics of Exercise 1 (f) Exercise Notice Aggregate Exercise Price 1 (d) st Transfer Agent rd DTC (a)]

By | 2016-10-12T14:34:31+00:00 October 12th, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: BIOSTAR PHARMACEUTICALS, INC. Issuance Date Date of Issuance:

[BIOSTAR PHARMACEUTICALS, INC. Issuance Date Date of Issuance: October [•], 2016 (“ Company Holder 1 16 Securities Purchase Agreement Biostar Pharmaceuticals, Inc., a Maryland corporation (the “ 1. Mechanics of Exercise 1 (f) Exercise Notice Aggregate Exercise Price 1 (d) st Transfer Agent rd DTC (a)]

By | 2016-10-12T14:35:52+00:00 October 12th, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING , Sept. 30, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday, November 7, 2016 at 9:00 ]

By | 2016-10-11T14:28:49+00:00 October 11th, 2016|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING

[Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING , Sept. 30, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday, November 7, 2016 at 9:00 ]

By | 2016-10-11T14:29:38+00:00 October 11th, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. Xianyang Yongsheng has three production lines, including health “Yuye” wine” (a popular brand in the PRC market), tea and capsules, and maintains a 24-acre Chinese herbal medicine ecological park. Mr. Wang Ronghua, the Chairman of Biostar, commented, “We have been following the developments of the] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 7, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐ ☐]

By | 2016-09-23T03:05:21+00:00 September 22nd, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals Signs a Letter of Intent to

[Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. Xianyang Yongsheng has three production lines, including health “Yuye” wine” (a popular brand in the PRC market), tea and capsules, and maintains a 24-acre Chinese herbal medicine ecological park. Mr. Wang Ronghua, the Chairman of Biostar, commented, “We have been following the developments of the] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 7, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐ ☐]

By | 2016-09-23T03:06:43+00:00 September 22nd, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar